During the International Aids Conference in Amsterdam, Dr Iain Barton, healthcare strategy executive at Imperial Logistics, gave a warning that more action is needed against the scourge of fake medicine in Africa.
In this online opinion piece, Mark Davison, head of operations in the EU for rfxcel, outlines everything marketing authorisation holders (MAHs) need to know and what is needed for a seamless serialisation process
After learning that pharma giant, Merck, has filed for a US patent for a blockchain-based system, GlobalData has been led to believe that the first applications of blockchain will initially be seen in the healthcare supply chain
As the deadline approaches for companies to be compliant with the new legislation to apply serialisation codes to every applicable pack of product, Gill Wright, design & development director, Cirrus, asks if you are ready for FMD…
In this interview with TraceLink’s Dan Walles, VP Global Solutions following his presentation at FutureLink Munich conference, we discuss automated software validation and how drug companies can benefit from it.
Five years on from the adoption of the EU falsified medicines directive (2011/62/EU) and the challenge continues. Here, Vincenzo Salvatore, BonelliErede (Milan), looks at the reasoning behind the directive and potential next steps
After a preview of TraceLink’s second annual Global Drug Supply, Safety and Traceability survey has revealed disparity in terms of readiness for the FMD between pharma companies and CMOs, three experts give us their perspectives on serialisation
As the falsified medicines directive is set to come into full force early next year, Christian Taylor, serialisation business consultant, Zetes, looks at the key challenges and practical questions relating to achieving compliance in more detail.
In this article, Marco Baietti, commercial director at SEA Vision, weighs up the advantages of implementing aggregation, what the future holds and the current levels of adoption within the industry.
Here, Scott Allison, president, Life Sciences & Healthcare, DHL, and Keith Turner, CIO Chief Development Office, Life Sciences & Healthcare, Service Logistics, DHL Supply Chain, look at the importance of blockchain in logistics.
In this online exclusive, FutureLink Munich speaker, Dr Andrew Rut, CEO and founder of MyMeds&Me, discusses how serialised medicine will revolutionise patient safety and engagement as well as adverse event reporting in the coming years.
Adrián Abad Fustero, Supply Chain Director of Medis, will be presenting at FutureLink Munich on the ‘The Virtual Broker: Negotiating Win-Wins with Track & Trace Partners’. In a preview of his presentation, we interviewed Fustero on the role of broker
